About This Site

Accel Research – DeLand is a trusted clinical research center dedicated to helping patients access new treatment options while advancing medical research. Established in 1998, our 25,000-square-foot, research-dedicated facility has decades of experience conducting Phase I–IV clinical trials.

Our experienced team provides a supportive, patient-focused environment where your safety, comfort, and privacy always come first. Equipped with a 60-bed Phase I unit for both inpatient and outpatient studies, and supported by a diverse clinical team, we partner with leading pharmaceutical and biotechnology companies to offer clinical trials across a wide range of health conditions—bringing innovative therapies to the DeLand community.

Conditions at this location

Migraine

Cannabis Use Disorder

Cannabis Withdrawal

Psoriasis

Atherosclerotic Cardiovascular Disease (ASCVD)

Type 2 Diabetes with Heart Disease

Covid-19 Vaccine

Diabetic Neuropathy

Epilepsy

Healthy Volunteer

Influenza Vaccine

Gout

Major Depressive Disorder (MDD)

Obesity

Weight Loss for Obesity

Pneumococcal Vaccine

RSV Vaccine

Schizophrenia

Smoking Cessation

Type 2 Diabetes

Providers at this location

Ready to be part of healthcare history? Find the right clinical trial for you.